Study social support to see effects after a bone marrow transplant
Part of Blood & lymphatic, Cancer clinical trials.
This study looks at how social relationships and support may affect “accelerated aging” in people soon after a bone marrow (hematopoietic cell) transplant. It may help researchers understand what kinds of support could improve health and recovery after transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older and able to consent for yourself
- You must be able to read, speak, and understand English
- You must have had a hematopoietic cell (bone marrow) transplant within the last 100 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks how certain blood “biomarkers” change after you receive donor stem cells to rebuild your blood and immune system. The goal is to learn whether these markers can better predict your immune recovery after transplant.
This study looks at natural killer (NK) cells, which are part of the immune system, in the blood of people who have had a stem cell transplant for acute leukemia or myelodysplasia. It aims to understand how these cells change after transplant and potentially predict outcomes.
This study looks at a personalized rehabilitation program for people who are eligible to receive a bone marrow transplant from a donor. The goal is to improve recovery and function after transplant.
This trial studies nutrition and nutritional status in people after a bone marrow (hematopoietic stem cell) transplant. It may help the hospital understand what nutritional support works best during recovery.
This study looks at how your body processes medications after a stem cell transplant from a donor. It aims to find the best way to test your genes to improve future treatments.
This study looks at how certain proteins in the blood around the time of a stem cell transplant may differ based on your blood disease and the type of donor you have. It aims to help doctors understand how to better support patients during stem cell transplants.
Hear when a new Hematopoietic and Lymphoid Cell Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.